Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
Ramos
A
A
Cruz
I
I
Muñez
E
E
Salas
C
C
Fernández
A
A
Alvarez-Espejo
T
T
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D018314:Leishmania infantum / Q000302:isolation & purification*; D016773:Leishmaniasis, Cutaneous / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy; D014605:Uveitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D019380:Anti-HIV Agents; D000981:Antiprotozoal Agents; D000666:Amphotericin B